Login
$GMAB
$51.51 +$0.14 (0.27%) Live

Company Executives

Officer Age In this role Source
Jan G. J. van de Winkel
President and Chief Executive Officer
64 Since 2010
16 years
Anthony Pagano
Executive Vice President and Chief Financial Officer
48 Not stated
Judith Klimovsky
Executive Vice President and Chief Development Officer
69 Not stated
Christopher Cozic
Executive Vice President and Chief People Officer
48 Not stated
Martine J. van Vugt
Executive Vice President and Chief Strategy Officer
55 Not stated
Rayne Waller
Executive Vice President and Chief Technical Operations Officer
58 Since 2024
2 years
Brad Bailey
Executive Vice President and Chief Commercial Officer
58 Not stated
Greg Mueller
Executive Vice President, General Counsel & Chief Legal Officer
54 Since 2025
1 year
Tahamtan Ahmadi
Executive Vice President and Chief Medical Officer, Head of Experimental Medicines
53 Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
9
serving now
Independent
5 of 9
stated in the proxy
Average tenure
8.8 years
from year joined
CEO also chairs the board
No
Deirdre P. Connelly and Pernille Erenbjerg
Director Age On board Independent Committees Source
Deirdre P. Connelly
65 2017
9 years
Independent
Audit and Finance Committee Compensation Committee Nominating and Corporate Governance Committee
Pernille Erenbjerg
58 2015
11 years
Independent
Audit and Finance Committee · Chair
Anders Gersel Pedersen
74 2003
23 years
Not independent
Nominating and Corporate Governance Committee · Chair Compensation Committee Scientific Committee
Paolo Paoletti
75 2015
11 years
Independent
Scientific Committee · Chair Compensation Committee
Rolf Hoffmann
66 2017
9 years
Independent
Audit and Finance Committee Scientific Committee
Elizabeth O’Farrell
61 2022
4 years
Independent
Compensation Committee · Chair Audit and Finance Committee
Martin Schultz
50 2022
4 years
Not independent None stated
Mijke Zachariasse
52 2019
7 years
Not independent None stated
Michael Kavanagh
52 2025
1 year
Not independent None stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. GENMAB A/S has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support